New Season of "I am BIO" Podcast Explores Patient Stories, Weight Loss Drugs, Food Security, and More
New Season of "I am BIO" Podcast Explores Patient Stories, Weight Loss Drugs, Food Security, and More
PR Newswire
WASHINGTON, Sept. 5, 2024
Series delves into biotech breakthroughs, the people they help, and the global problems they solve
WASHINGTON, Sept. 5, 2024 /PRNewswire/ -- The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning "I am BIO" podcast on September 10. Now entering its fifth year, the podcast explores the intersection of biotechnology, life sciences, environment, and agriculture. "I am BIO" highlights stories of resilience, discovery, and the profound impact biotech has on patients and society as a whole.
Kicking off the fall season, the podcast will feature David Fajgenbaum, MD, MBA, MSc, FCPP, a national bestselling author of "Chasing My Cure: A Doctor's Race to Turn Hope into Action." Dr. Fajgenbaum recounts his extraordinary journey from medical student to patient as he fought against a life-threatening disease. Through sheer determination and scientific acumen, Fajgenbaum uncovered an existing drug that could be repurposed to treat his disease—a discovery that saved his life and is now saving others.
This season's "I am BIO" offers more insights into the world of biotechnology with upcoming episodes that will explore:
- The role of biotechnology in enhancing food security
- Inspiring patient stories and treatments in the pipeline that can help them
- The importance of biotechnology to national security
- GLP-1 drugs, benefits beyond weight loss
- Biotech solutions that support age-related health issues
Listen to past episodes on BIO's website, Apple Podcasts, Google Podcasts, or Spotify.
About BIO
The Biotechnology Innovation Organization (BIO) is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
Contact: Theresa Brady
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-season-of-i-am-bio-podcast-explores-patient-stories-weight-loss-drugs-food-security-and-more-302239597.html
SOURCE Biotechnology Innovation Organization (BIO)
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk